These 20 women are 2018's Fiercest in the life sciences industry.
Read 2018's Fiercest Women in Life Sciences report!
Merck KGaA has licensed a cloud-based artificial intelligence proteome screening platform from the Toronto-based Cyclica.
The new Apple Watch’s electrocardiogram capability has gone live, available as a free software update that allows for wrist-based ECGs on the go.
Myriad showed new data for its EndoPredict test, saying it can forecast which women with breast cancer will see the most benefits from chemotherapy.
Precision immunodiagnostic firm Navidea Biopharmaceuticals named Michael Rosol, Ph.D., to be its new chief medical officer, effective Dec. 17.
Medtronic will pay nearly $51 million to settle claims against two of its acquisitions related to unapproved device promotions and alleged kickbacks.
Fresenius dramatically widened its footprint in China, acquiring shares in multiple Chinese companies and hospital systems.
Sanofi and Sema4 launched a five-year study of nearly 1,200 asthma patients, incorporating digital tools to better understand the disease.
Australian researchers discovered a unique DNA structure that could be used to help diagnose cancer in under 10 minutes with the naked eye.
Siemens Healthineers held a ribbon-cutting ceremony for its $300 million expansion of its manufacturing and R&D facility in Walpole, Massachusetts.
The FDA granted Bayer and Merck breakthrough device status for AI-based software that spots a rare form of pulmonary hypertension in CT scans.
